June 6th 

NeuroPath represents UK at Western Balkans Technology Trade Mission

NeuroPath Biosciences was selected to represent the UK at the British Chamber of Commerce Technology Trade Mission to the Western Balkans, joining senior government and industry figures in Belgrade. NeuroPath is now leading the British-Serbia mission strand in partnership with Cambridge Wireless.

June 7th

CTO Stephan Munroe wins NVIDIA Open-Source AI Hack for Impact

NeuroPath Co-Founder & CTO Stephan Munroe took top honours at the NVIDIA Open-Source AI Hack for Impact in London with project WaitWise demonstrating the team's AI capability and commitment to socially impactful technology.

June 18th

NeuroPath selected for Cambridge Tech Week Innovation Alley

NeuroPath Biosciences has been selected to participate in Cambridge Tech Week's Innovation Alley, showcasing our multimodal diagnostic platform to investors, industry leaders, and the wider Cambridge tech ecosystem.

June 22nd

 Joins ARU Imagine 2036 as Industry Expert Panellist

Founder & CEO Rob Pegram joined Anglia Ruskin University's Imagine 2036 event in Cambridge, speaking on AI and clinical diagnostics exploring how agentic AI will transform mental health triage in primary care over the next decade.